Published in Am J Epidemiol on January 01, 1979
Dignity and the essence of medicine: the A, B, C, and D of dignity conserving care. BMJ (2007) 2.80
Increased rate of suicide among patients with Huntington's disease. J Neurol Neurosurg Psychiatry (1984) 2.31
Incidence of suicide in persons with cancer. J Clin Oncol (2008) 2.21
Cigarettes and suicide: a prospective study of 50,000 men. Am J Public Health (2000) 2.09
Suicide in patients with pancreatic cancer. Cancer (2010) 1.62
Smoking and suicide among nurses. Am J Public Health (1993) 1.36
Suicides among Danish cancer patients 1971-1999. Br J Cancer (2005) 1.28
Immediate risk for cardiovascular events and suicide following a prostate cancer diagnosis: prospective cohort study. PLoS Med (2009) 1.26
High suicide mortality soon after diagnosis among cancer patients in central Italy. Br J Cancer (1998) 1.03
Suicide in cancer patients in South East England from 1996 to 2005: a population-based study. Br J Cancer (2009) 0.98
The health status of elderly persons in the last year of life: a comparison of deaths by suicide, injury, and natural causes. Am J Public Health (1997) 0.96
Hospital admissions and deaths relating to deliberate self-harm and accidents within 5 years of a cancer diagnosis: a national study in Scotland, UK. Br J Cancer (2007) 0.95
Clinical predictors of completed suicide and repeated self-poisoning in 8895 self-poisoning patients. Eur Arch Psychiatry Neurol Sci (1990) 0.79
Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes. Lancet (1987) 6.91
Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studies. BMJ (2004) 6.48
Risk of cancer after low doses of ionising radiation: retrospective cohort study in 15 countries. BMJ (2005) 4.91
The 15-Country Collaborative Study of Cancer Risk among Radiation Workers in the Nuclear Industry: estimates of radiation-related cancer risks. Radiat Res (2007) 4.41
Serum concentrations of prostate specific antigen and its complex with alpha 1-antichymotrypsin before diagnosis of prostate cancer. Lancet (1994) 2.83
Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes Control (2000) 2.24
Evaluation of screening programmes for gynaecological cancer. Br J Cancer (1985) 2.06
Fallout from Chernobyl and incidence of childhood leukaemia in Finland, 1976-92. BMJ (1994) 2.04
Effect of a mass screening program on the risk of cervical cancer. Am J Epidemiol (1976) 1.97
Indoor radon exposure and risk of lung cancer: a nested case-control study in Finland. J Natl Cancer Inst (1996) 1.93
Cervical cancer screening programmes and policies in 18 European countries. Br J Cancer (2004) 1.88
Report on a Workshop of the UICC Project on Evaluation of Screening for Cancer. Int J Cancer (1990) 1.84
Gynaecological infections as risk determinants of subsequent cervical neoplasia. Acta Oncol (2000) 1.71
UICC project on screening for cancer: report of the workshop on screening for breast cancer. Meeting held in Helsinki, Finland, on April 7-9, 1986. Int J Cancer (1986) 1.60
Chlamydia trachomatis infection as a risk factor for invasive cervical cancer. Int J Cancer (2000) 1.58
Outcome-based equity in the treatment of colon cancer patients in Finland. Int J Technol Assess Health Care (1989) 1.57
Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963-1995: recent increase in cervical cancer incidence. Int J Cancer (1999) 1.56
Selective screening: theory and practice based on high-risk groups of cervical cancer. J Epidemiol Community Health (1979) 1.48
Programme sensitivity and effectiveness of mammography service screening in Helsinki, Finland. J Med Screen (2002) 1.45
Serum vitamin E and risk of cancer among Finnish men during a 10-year follow-up. Am J Epidemiol (1988) 1.45
Healthy worker effect in the total Finnish population. Br J Ind Med (1980) 1.39
Incidence and mortality from breast cancer in the Mama Program for Breast Screening in Finland, 1973-1986. Cancer (1994) 1.38
Serum cholesterol and risk of cancer in a cohort of 39,000 men and women. J Clin Epidemiol (1988) 1.38
The 15-Country Collaborative Study of Cancer Risk Among Radiation Workers in the Nuclear Industry: design, epidemiological methods and descriptive results. Radiat Res (2007) 1.37
Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: an international collaborative study among cancer registries. Int J Cancer (1987) 1.37
Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised setting. Br J Cancer (2005) 1.37
Mass screenings for cervical cancer in Finland 1963-71. Organization, extent, and epidemiological implications. Ann Clin Res (1975) 1.36
Reliability of histopathologic diagnosis of malignant lymphoma. Ann Clin Res (1973) 1.35
Serum selenium and subsequent risk of cancer among Finnish men and women. J Natl Cancer Inst (1990) 1.33
Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer. J Natl Cancer Inst (1997) 1.29
Process indicators from ten centres in the Finnish breast cancer screening programme from 1991 to 2000. Eur J Cancer (2004) 1.27
The effect of mass screening on incidence and mortality of squamous and adenocarcinoma of cervix uteri. Obstet Gynecol (1995) 1.27
Ca 15-3 in the follow-up of localised breast cancer: a prospective study. Eur J Cancer (2002) 1.24
Human papillomavirus infection, risk for subsequent development of cervical neoplasia and associated population attributable fraction. J Clin Virol (2001) 1.23
Organised vs. spontaneous Pap-smear screening for cervical cancer: A case-control study. Int J Cancer (1999) 1.23
Radon and lung cancer in Finland. Health Phys (1996) 1.23
Defects of the central nervous system in Finland: I. Variations in time and space, sex distribution, and parental age. Br J Prev Soc Med (1977) 1.23
Cardiovascular drug use and the incidence of erectile dysfunction. Int J Impot Res (2006) 1.20
Selective screening for cervical cancer. Experience of the Finnish mass screening system. Br J Prev Soc Med (1977) 1.18
Prevalence, incidence, and estimated life-time risk of cervical human papillomavirus infections in a nonselected Finnish female population. Sex Transm Dis (1990) 1.17
Lumpectomy with or without postoperative radiotherapy for breast cancer with favourable prognostic features: results of a randomized study. Br J Cancer (2001) 1.15
Mortality and morbidity among the working population of anthophyllite asbestos miners in Finland. Br J Ind Med (1974) 1.13
Cancer in Finland 1953-1970: incidence, mortality, prevalence. Acta Pathol Microbiol Scand Suppl (1975) 1.12
DNA flow cytometric analysis indicates that many breast cancers detected in the first round of mammographic screening have a low malignant potential. Int J Cancer (1988) 1.10
A randomized trial of choice of treatment in prostate cancer: the effect of intervention on the treatment chosen. BJU Int (2004) 1.09
European randomized study of prostate cancer screening: first-year results of the Finnish trial. Br J Cancer (1999) 1.09
Regional and temporal variation in the incidence of multiple sclerosis in Finland 1979-1993. Neuroepidemiology (2000) 1.08
Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017. Acta Oncol (1997) 1.07
Increased risk of malignant lymphoma indicated by elevated Epstein-Barr virus antibodies--a prospective study. Cancer Causes Control (1993) 1.07
Effectiveness of routine and spontaneous follow-up visits for breast cancer. Eur J Cancer Clin Oncol (1989) 1.06
UICC Workshop on the evaluation of screening programmes for cancer. Int J Cancer (1984) 1.06
Varicose veins in a Finnish population aged 40-60. J Epidemiol Community Health (1993) 1.04
Reduced breast-cancer mortality with mammography screening--an assessment of currently available data. Int J Cancer Suppl (1990) 1.04
Sheep and goats: separating cervix and corpus uteri from imprecisely coded uterine cancer deaths, for studies of geographical and temporal variations in mortality. Eur J Cancer (2004) 1.03
Predicting the outcome of prostate biopsy in screen-positive men by a multilayer perceptron network. Urology (2000) 1.03
Projection of cancer incidence: experiences and some results in Finland. World Health Stat Q (1980) 1.03
Serum vitamin E, serum selenium and the risk of gastrointestinal cancer. Int J Cancer (1988) 1.03
Combined effect of asbestos exposure and tobacco smoking on Finnish anthophyllite miners and millers. Ann N Y Acad Sci (1979) 1.02
Implementation of colorectal cancer screening in Finland: experiences from the first three years of a public health programme. Z Gastroenterol (2008) 1.01
Overexpression of p53 and long-term survival in colon carcinoma. Br J Cancer (1994) 1.01
Failure of selective screening for breast cancer by combining risk factors. Int J Cancer (1978) 0.99
UICC workshop of the Project on Evaluation of Screening Programmes for Gastrointestinal Cancer. Int J Cancer (1986) 0.99
Loss-adjusted survival of cervix cancer in Khon Kaen, Northeast Thailand. Br J Cancer (2004) 0.98
Serum testosterone and sex hormone-binding globulin concentrations and the risk of prostate carcinoma: a longitudinal study. Cancer (1999) 0.98
Prognostic effect of timing of operation in relation to menstrual phase of breast cancer patient--fact or fallacy. Br J Cancer (1995) 0.98
Risk indicators of breast and cervical cancer on ecologic and individual levels. Am J Epidemiol (1982) 0.98
Breast self-examination and survival from breast cancer: a prospective follow-up study. Breast Cancer Res Treat (1996) 0.97
No excess risk of cervical carcinoma among women seropositive for both HPV16 and HPV6/11. Int J Cancer (1999) 0.97
Cervical cancer incidence and mortality trends in Finland and Estonia: a screened vs. an unscreened population. Eur J Cancer (1993) 0.96
Cereal consumption and gastric cancer. Int J Cancer (1967) 0.96
Increasing prevalence of multiple sclerosis in Finland. Acta Neurol Scand (2001) 0.96
Serum vitamin A and subsequent risk of cancer: cancer incidence follow-up of the Finnish Mobile Clinic Health Examination Survey. Am J Epidemiol (1990) 0.96
Oral cancers in Mumbai, India: a fifteen years perspective with respect to incidence trend and cumulative risk. Asian Pac J Cancer Prev (2004) 0.95
Survival trends for neuroblastoma patients in Finland: negative reflections on screening. Eur J Cancer (1992) 0.95
Bleeding symptoms and subsequent risk of gynecological and other cancers. Acta Obstet Gynecol Scand (1998) 0.95
Incidence of cancer among anthophyllite asbestos miners in Finland. Occup Environ Med (1994) 0.95
Way of life and cancer incidence in Finland. Scand J Soc Med Suppl (1980) 0.94
Prevalence of lower urinary tract symptoms in Finnish men: a population-based study. Br J Urol (1998) 0.93
Association of non-urological diseases with lower urinary tract symptoms. Scand J Urol Nephrol (2001) 0.93
Estimating the expectation of life in cancer survival studies with incomplete follow-up information. J Chronic Dis (1977) 0.93
Insulin-like growth factor I is not a useful marker of prostate cancer in men with elevated levels of prostate-specific antigen. J Clin Endocrinol Metab (2000) 0.93
Smoking and risk of colorectal cancer. Br J Cancer (1998) 0.93
Association of smoking with lower urinary tract symptoms. J Urol (1998) 0.93
Defects of the central nervous system in Finland. II. Birth order, outcome of previous pregnancies and family history. Teratology (1978) 0.92
Risk factors for contralateral breast cancer in Chennai (Madras), India. Int J Epidemiol (1998) 0.91
Joint effects of different human papillomaviruses and Chlamydia trachomatis infections on risk of squamous cell carcinoma of the cervix uteri. Eur J Cancer (2004) 0.91
The sense of coherence, occupation and all-cause mortality in the Helsinki Heart Study. Eur J Epidemiol (2003) 0.91
Serum tumor markers CEA, CA 50, TATI, and NSE in lung cancer screening. Cancer (1993) 0.90
Serum micronutrients and risk of cancers of low incidence in Finland. Am J Epidemiol (1991) 0.90
Cancer in Finland 1954-1963. Ann Clin Res (1969) 0.90
Hysterectomy and subsequent risk of cancer. Int J Epidemiol (1997) 0.90
Vitamin E and cancer prevention. Am J Clin Nutr (1991) 0.90
Predictions of epidemiology and the evaluation of cancer control measures and the setting of policy priorities. Soc Sci Med (1991) 0.89
Specificity of serum prostate-specific antigen determination in the Finnish prostate cancer screening trial. Br J Cancer (2007) 0.89
The visibility of cancer on earlier mammograms in a population-based screening programme. Eur J Cancer (1999) 0.88
The Finnish trial of prostate cancer screening: where are we now? BJU Int (2003) 0.88
Follow-up cost of breast cancer patients with localized disease after primary treatment: a randomized trial. Breast Cancer Res Treat (2005) 0.88
Risk of cervical cancer after a negative Pap smear. J Med Screen (1999) 0.87
Epidemiological evidence for two components of cervical cancer. Br J Obstet Gynaecol (1981) 0.87